Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan

BACKGROUND: Global prevalence of Hepatitis C Virus (HCV) infection corresponds to about 130 million HCV positive patients worldwide. The only drug that effectively reduces viral load is interferon-α (IFN-α) and currently combination of IFN and ribavirin is the choice for treatment. OBJECTIVES: The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwal, Sobia, Mahmood, Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412557/
https://www.ncbi.nlm.nih.gov/pubmed/22879830
http://dx.doi.org/10.5812/hepatmon.6184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412557/
https://www.ncbi.nlm.nih.gov/pubmed/22879830
http://dx.doi.org/10.5812/hepatmon.6184

Ejemplares similares